NASDAQ
ANI Pharmaceuticals, Inc. (ANIP) has a revenue compound annual growth rate of 33.48% over 5 years and 27.75% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.